STATE STREET CORP - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q1 2022$458,000
-30.6%
412,7680.0%0.00%
Q4 2021$660,000
-34.2%
412,7680.0%0.00%
Q3 2021$1,003,000
+304.4%
412,768
+427.8%
0.00%
Q2 2021$248,000
+359.3%
78,200
+373.5%
0.00%
Q4 2019$54,000
+12.5%
16,5160.0%0.00%
Q3 2019$48,000
+20.0%
16,5160.0%0.00%
Q2 2019$40,00016,5160.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 6,220,938$16,299,0000.94%
Boxer Capital, LLC 4,029,649$10,558,0000.36%
DAFNA Capital Management LLC 199,425$522,0000.17%
J. Goldman & Co LP 443,517$1,162,0000.08%
Ikarian Capital, LLC 1,196,308$688,0000.05%
HHLR ADVISORS, LTD. 1,598,185$4,187,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 133,634$350,0000.02%
F3Logic, LLC 255$668,0000.02%
Schonfeld Strategic Advisors LLC 343,195$899,0000.02%
CSS LLC/IL 54,773$144,0000.01%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders